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        Summary 
 
 
 
At M-phase onset, rapid M-phase Promoting Factor (MPF; the cyclin 
B-cdk 1 complex) activation is granted by an activation loop in which 
the cdc25C phosphatase removes inhibitory phosphorylations of cdk1 
at thr-14 and tyr-15, while MPF stimulates cdc25C activity and 
inhibits activity of wee1, the cdk1 tyr-15 kinase. At M-phase exit, 
ubiquitin-dependent cyclin proteolysis inactivates MPF. Here we show 
that timely activation of proteolysis requires interruption of the MPF 
activation loop. By sampling Xenopus egg extracts at very short 
intervals during both meiotic and mitotic exit, we found that cyclin B1-
associated cdk1 underwent transient inhibitory phosphorylation at tyr-
15 and that cyclin B1-cdk1 activity fell more rapidly the cyclin B1 
content. Concomitantly, cdc25C underwent inhibitory phosphorylation 
at ser-287. In addition, we detected physical interaction between Wee1 
and MPF in M-phase. MPF inactivation required Ca++/calmodulin-
dependent kinase II (CaMKII) and cAMP-dependent protein kinase 
(PKA) activities at meiosis and mitosis exit respectively. 
Supplying extracts with mutant cyclin B1-cdk1AF complex, refractory 
to inhibition by phosphorylation, altered M-phase exit. Loss of MPF 
activity was required for full binding of the ubiquitin ligase Anaphase 
Promoting Complex /Cyclosome (APC/C) to its co-activator Cdc20. 
Thus, M-phase exit requires a tight coupling of proteolysis-dependent 
and proteolysis-independent mechanisms of MPF inactivation. 
 
 
 
 
 
 
 
                 Cdk-Cyclin complexes and their oscillatory                    
        properties 
 
 
The primary task of the cell division cycle is to duplicate genetic 
information precisely through the process of DNA replication (S phase) 
and then to allocate this information equally to two daughter cells through 
mitosis. In eucariotic cells each phase of the cell cycle is controlled by 
several Cyclin Dependent Kinases with their obligate activating partners, 
the Cyclins. Once activated these kinases are known to modify various 
substrate whose activity is critical for cell cycle progression. 
The activation of Cdks is mediated by the sequential accumulation of 
cyclins, that once bind to their specific partner subunits begin a wave of 
phosphorylations events that ultimately leads to the completion of a 
particular cell cycle phase. The end of one phase and the beginning of the 
other is mediated by the desctruction of the cyclin wave through 
proteolysis. Other mechanisms coupled tightly to degradation restrict CDK 
activity to a specific phase of the cell cycle, the controlled degradation of 
Cyclins is an irreversible mechanisms that blocks the way back, thus 
driving the cell cycle in only one direction. The tight control through 
proteolysis and localization of the Cyclin activity represents an important 
feature of the mammalian cell cycle, complex mechanisms called 
checkpoints restrict wave diffusion in a spatially and timely coordinated 
manner. The disruption of Cdk’s activity control through defect in 
proteolysis or localization leads to abnormal completion of the cell cycle 
and the acquisition of a feature typical of the cancer cell: genomic 
instability.   
 
 
Fig.2 depicts the cyclin waves during cell cycle progression, the model is 
simplified highlighting only the contribution of three maor cdk activity: S-
cdk, M cdk and G1 cdk; the cell cycle is completed by the proteolysis of 
the M Cyclin wave mediated by the ubiquitin ligase APC/C(see below for 
further details). 
 In a simple organism like yeast is only the availability of nutrients that 
allows a cell in G1 to grow in size and enter the cell cycle.  The decision to 
start the cell cycle is taken at a specific G1 checkpoint called START in 
yeast and renamed "restriction point" in mammalian cells.  After this point 
the cell is committed to replicate its genome and divide.  After G1, during 
the "S phase" (phase of DNA synthesis), the cell replicates its genome and 
then enters the short G2 phase during which key mechanisms control the 
completion and fidelity of DNA replication and prepare the cell for 
entering mitosis.  Mitosis or "M-phase" is the shortest and the most 
dramatic phase since at this time the replicated genome is segregated to the 
opposite pole of the cell and the two daughter cells are generated. 
 The molecular mechanisms of cell cycle regulation were first reveled by 
the genetic dissection of the yeast cell cycle through the isolation and study 
of the cell division cycle (cdc) mutants.  Of fundamental importance was 
the discovery that a gene called CDC28 in Saccharomyces Cerevisiae and 
cdc2 in Schizosaccharomyces Pombe is the master controller of both G1/S 
and G2/M transitions in these organisms (Nasmyth and Nurse 1981).  It 
was then shown that cdc2/CDC28 encodes a serine/threonine kinase whose 
activity oscillates during the cell cycle.  During different phases of the cell 
cycle cdc2/CDC28 associates with different activating subunits called 
cyclins because of their property of accumulating at specific phases of the 
cell cycle.    
After those observations the purification of the MPF from the X. Laevis 
egg extract leaded to the isolation of  the cdc2 and cyclin B 
complex(Labbe, Capony et al. 1989) and the major acting route of 
oscillation of the Cyclin dependent kinases with their cyclin activating 
partners was uncovered. In '87 a family of mammalian kinases homologues 
to Cdc2/CDC28 was identified(Draetta, Brizuela et al. 1987) 
In contrast to yeast, where the cell cycle and, therefore, proliferation is 
mainly controlled by the presence of nutrients, in mammalian cells a more 
complex system of growth control has evolved. The rules imposed by 
multicellular organization requires that proliferation, differentiation and 
programmed cell death (apoptosis) be restricted by extracellular events 
such as the presence of soluble growth. factors and cell-cell contact 
interaction.  Nevertheless, control of the various phases of the cells cycle 
requires similar protein modules of kinases controlled by phosphorylation 
and de-phosphorylation events, unstable activating (cyclins) and inhibitory 
(ckis) subunits(Sherr and Roberts 2004).   
 
 
Fig.1 The picture depicts a simplified model of cell cycle transition that highlights the contribution of 
only three major cdk waves respectively  called as G1 cdks, S cdks, Mcdks, The metaphase- anaphase 
transition is signed by the activation of the APC/C that degrades Cyclin B and interrupt the mitotic cyclin 
wave.  
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                  Use of Xenopus laevis system to study cell cycle   
          transitions 
 
 
 
 
 During the last 10 years a great advancement in the comprehension of cell 
cycle mechanisms has been achieved, the presence of model systems like 
Xenopus laevis helped tremendously in the biochemical characterization of 
cyclin B degradation and mitosis exit. The system has been used in a 
multitude of approaches to address questions regarding not only cell cycle 
regulation  but also DNA damage, apoptosis, chromatin remodeling and 
nuclear transport ( for an extensive review see methods mol bio 2006 
vol.322). The system is based on the embryonic cycle of the south African 
clawed frog Xenopus Laevis, and exploits the process of oocyte 
fertilization and the early embryonic division.  
Fully grown, immature stage VI oocytes present in the ovaries of adult 
frogs are arrested at the G2/M transition of meiosis I. On progesterone (PG) 
secretion in vivo by the neighboring follicle cells of the ovary in response 
to pituitary hormones, or on PG addition in culture, the oocytes enter 
meiosis I and proceed with the process termed “oocyte maturation,” 
ultimately resulting in a fertilizable egg. The egg is arrested in metaphase II 
of meiosis by a factor called CSF (Cytostatic factor ), whose component 
have been dissected during the past years(Tunquist and Maller 2003) 
(D'Angiolella, Costanzo et al. 2001). The CSF maintain an high activity of 
MPF and the addition of Calcium, mimicking the process of fertilization, 
allows the exit from metaphase II of meiosis. The extract is prepared from 
metaphase II arrested eggs, upon calcium addition in vitro a series of events 
stimulated by CAMKII trigger cyclin B degradation,  partially 
phenocopying the process of mitosis exit in mammalian cells. The process 
of fertilization can also be triggered when the egg is intact by using calcium 
ionophore. When the extract is prepared the eggs undergo different round 
of MPF oscillation, the process in vitro reproduces the early embryonic 
division after fertilization. Fig 3 explain the difference and the behaviour of 
a cycling extract and a CSF extract. It is shown the MPF activity oscillation 
upon calcium addition or after the preparation of cycling extract.  
Another possibility is to study cell cycle checkpoint in Xenopus laevis egg 
extract, for example the spindle checkpoint can be induced by adding to the 
extract nuclei and nocodazole. Nuclei and nocodazole represent a source of 
unattached kinethochores that send a wait signal for cyclin B degradation 
and mitosis exit.      
     
 
 
 
Fig.2 In the picture is shown a model of cell cycle transition during early embryogenesis of the African 
clawed frog Xenopus Laevis. The extract is prepared using eggs physiologically arrested in the metaphase 
II of meiosis or using the eggs that undergo different cycle of rapid S-M phase after parthenogenetic 
activation. The extract can be arrested in mitosis by adding nuclei and nocodazole. Nuclei and nocodazole 
simulate the signal present in vivo during an active “spindle checkpoint”. 
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       Unravelling frog and human control of G2/M   
       transition 
 
 
 
 
 
Over 30 years ago, Yoshio Masui and Clement Markert (1971) published 
an historic paper describing cytoplasmic control over the behavior of nuclei 
of both meiotic and mitotic cells. This paper described an activity in the 
cytoplasm of eggs from the leopard frog Rana pipiens that was able to 
initiate oocyte maturation when injected into immature G2-arrested 
oocytes, an activity they termed maturation-promoting factor (MPF). 
Since MPF activity is also present in mitotic cells, MPF has subsequently 
come to stand for M-phase promoting factor.  The essential component of 
MPF is the cyclin B-Cdk1 complex.  Cyclin B levels are regulated 
transcriptionally, at the level of mRNA stability and by proteolysis.  Cyclin 
B is not detectable until the end of S-phase. Once the cyclin B-Cdk1 
complex is formed, it is stabilized by phosphorylation by the Cdk-
activating kinase (CAK), the activity of which appears constitutive 
throughout the cell cycle(Thuret, Valay et al. 1996).  The major control on 
Cdk1 Cyclin B complex in the G2/M phase of the cell cycle is exerted by 
phosphorylation in the ATP cleft of Cdk1 on the thr14 and tyr 15 residues 
by Wee1 and Myt1 while  its dephosphorylation and hence activation is 
achieved by the Cdc25 phosphatases(Krek, Marks et al. 1992).  Premature 
entry into mitosis is prevented by keeping the cyclin B-Cdk1 complex in its 
inactive, phosphorylated state.  This is accomplished by enhancing Wee1 
activity or by inhibiting the Cdc25 phosphatase activity.  Studies on the 
Cdc25 proteins from Xenopus, humans, and fission yeast have shown that 
Cdc25 is hyperphosphorylated during mitosis relative to during interphase, 
and that this leads to a significant enhancement of its phosphatase activity 
(Dunphy 1994)(Fig. 3). Similar studies on Xenopus and human Weel have 
also uncovered mitotic hyperphosphorylation, in this case leading to an 
inhibition of its kinase activity (Hoffmann, Clarke et al. 1993; McGowan 
and Russell 1995; Mueller, Coleman et al. 1995; Watanabe, Broome et al. 
1995). Cdc2 contributes to these hyperphosphorylations, but other kinases 
also play a role in Cdc25 and Wee1 phosphorylation. 
In human three different genes code for cdc25 phosphatases respectively 
named cdc25A, B and C; the three different forms exert specific function 
during the cell cycle and Cdc25c is mainly implicated in controlling mitosis 
entry. The control of Cdk1 cyclin B through Cdc25c ad Wee1 is extremely 
important to the timely progression of the cell cycle, the inhibition of cdk 
activity during S- phase prevents the beginning of mitosis if the DNA 
replication is not completed or if  DNA is damaged. Any of this two 
checkpoints( Dna damage or Dna replication) activates a complex response 
that  culminates in the activation of two different kinases called Chk1 ad 
Chk2(Sancar, Lindsey-Boltz et al. 2004). Both Chk1 and Chk2 can 
phosphorylate Cdc25c on Ser287 (human Ser216), which creates a binding 
site for 14-3-3. The mechanisms by which phosphorylation of this residue 
and 14-3-3 binding suppress Cdc25c’s ability to dephosphorylate cdc2, 
including changes in its subcellular localization in some types of cell cycles 
are still being worked out. 
Kumagai et al. (1998b) were the first to suggest that phosphorylation of 
Cdc25c on Ser287 might also play a role in normal cell cycles. This idea 
was based on observations that a significant amount of endogenous cdc25C 
coprecipitated with 14-3-3 from unperturbed Xenopus egg interphase 
extracts and that association of 14-3-3 with recombinant Cdc25c protein 
was dependent on Cdc25c phosphorylation on Ser287. In addition to the 
checkpoint kinases, several others can phosphorylate Cdc25c on Ser287. 
Protein kinase A (PKA), a well-known inhibitor of the G2/meiosis I 
transition, helps to maintain Xenopus oocytes in their natural G2 arrest 
through phosphorylation of cdc25C on Ser287 (Duckworth, Weaver et al. 
2002; Schmitt and Nebreda 2002). In fertilized Xenopus eggs, calmodulin-
dependent protein kinase II (CaMKII) seems to be responsible for the 
majority of Ser287 phosphorylation during interphase of the first mitotic 
cell cycle (Hutchins, Dikovskaya et al. 2003)  
 During mitosis, Cdc25c becomes phosphorylated at multiple sites by 
Cdc2, leading to the formation of hyperphosphorylated, electrophoretically 
retarded forms (Izumi, Walker et al. 1992; Kumagai and Dunphy 1992). 
The Cdc2- dependent mitotic phosphorylation of Cdc25c on Ser285 
(human Ser214) seems to prevent rephosphorylation of Ser287 during 
mitosis, presumably strengthening the positive feedback loop (Bulavin, 
Demidenko et al. 2003; Bulavin, Higashimoto et al. 2003). On Wee1 the 
regulation appears to be very similar to that of cdc25; the Ser549 residue of 
Wee1 is phosphorylated during checkpoint arrest and the phosphorylation 
increases Wee1 activity (Stanford, Lieberman et al. 2003; Stanford and 
Ruderman 2005). Fig.3 shows a model of cdk activation during the 
transition from G2 to mitosis, based on the different phosphorylation state 
of Cdc25c and Wee1, the mechanism is quite different “in vivo” as many 
other factors contribute to cdk regulation for example the relative 
localization of Cdc25c or cdk1, or the phosphorylation of different residues 
on Cdc25c and Wee1.  
 
 
 
 
 Fig.3  The picture shows the different phosphorilation state of cdc25c and Wee1 during g2 arrest and 
mitosis. During interphase cdc25c is inhibited and phosphorylated on the Ser285 residue (Ser216 in 
human) by different kinases, on the contrary wee1 is phosphorylated and activated, this keeps 
Cdk1/cyclin B in low activation state because maintain Tyr15 phosphorylation in the ATP cleft of Cdk1. 
The transition from G2 to mitosis is signed by an abrupt increase of cdk1 activity determined by the 
autoamplification loop exerted by the Cdk1/cyclin B complex, that phosphorylates cdc25c on Ser285 
increasing its activity, hence providing an autoamplification loop required for cdk activation.     
 
 
 
APC/C and SCF destruction in cell cycle 
control 
 
Ubiquitin-dependent proteolysis ensures that specific protein functions are 
turned off at the right time, in the right place and in a unidirectional 
fashion. The high substrate specificity of the system is determined by a 
large family of ubiquitin ligases, which competes with the protein kinases 
to be the largest family of enzymes in mammals.  Given the crucial 
function of the proteolytic machinery, altered degradation of cell cycle 
regulators contributes to the unchecked proliferation typical of cancer cells.  
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In order to keep a cell healthy, proteins need to be destroyed in a 
timely fashion.  Regulated protein degradation offers the advantage of 
switching off a function in a specific subcellular compartment while 
leaving the others untouched, a task that the cell could not perform if 
protein abundance was regulated only by synthesis.  In addition, proteolysis 
has the advantage of being fast, as a large number of different proteins can 
be eliminated in a matter of minutes.  Finally, proteolysis is irreversible, an 
essential quality to permanently eliminate a protein in unidirectional 
processes such as cell cycle.  Cells deploy the ubiquitin-proteasome system 
to degrade cellular regulatory proteins, thus monitoring their abundance.  
The targeting of a substrate to the 26S proteasome requires the covalent 
attachment of polyubiquitin chains to one or multiple lysine residues of the 
substrate.  Upon association with the proteasome, the substrate is fed into 
the catalytic core where it is proteolyzed.  Protein ubiquitinylation is a 
multistep process orchestrated by the concerted action of three enzymes: 
ubiquitin-activating enzyme (E1); ubiquitin-conjugating enzyme (Ubc or 
E2); and ubiquitin-protein ligase (E3).  The latter recruits the target, guides 
the transfer of the ubiquitin from the Ubc to the substrate and allows for 
elongation of the ubiquitin chain (Hershko and Ciechanover 1998).  Given 
the diversity of the target proteins, there is a correspondingly large number 
of E3s.  Proteolysis of many core components of the cell cycle machinery 
is controlled by two major classes of ubiquitin ligases: the SCF (Skp1-
Cul1-F-box protein + Roc1/Rbx1) complexes and the Anaphase Promoting 
Complex/Cyclosome (APC/C).  Both complex share a similar core 
organization ( the association of a cullin-like protein[Cdc53 in SCF and 
APC2 in APC] with a protein containing a particular zinc finger domain[ 
Rbx1 in SCF and APC11 in APC]) and possibly a common origin 
(Vodermaier 2004). Despite these similarities they are regulated in 
different ways. The SCF complex is active throughout the cell cycle and 
the destruction of its substrates depends on their phosphorylation, with 
different phosphate binding proteins (F box proteins) guiding different set 
of substrate destruction. The APC/C is activated at the onset of anaphase 
and degrades its substrate as the cell exit mitosis, two cofactor called 
Cdc20 and Cdh1 bind and activate the APC/C ( see below for further 
details) .  
    In human, there are sixty-eight SCF ligases, each characterized by 
a different F-box protein subunit that provides specificity by directly 
recruiting the substrate to the rest of the ligase and, ultimately, to the 
ubiquitin conjugating enzyme (UBC)(Cardozo and Pagano 2004).  
There is a high level of crosstalk between APC/C and different type 
of SCF and interdependency is required for the progression through the cell 
cycle. One example is SKP2 a leucine rich repeat F_box protein that target 
the cdk inhibitors p21Cip1, p27 Kip1 and p57Kip2for degradation, thus 
promoting entry into S phase. The G1- S transition marks the commitment 
for another round of cell division and the level of Skp2 are tightly 
controlled trough autoubiquitination and ubiquitination by APC/CCdh1. The 
degradation of Skp2 during G1 keeps the level of inhibitors of Cdk high, 
thus preventing a premature entry into the cell cycle(Bashir, Dorrello et al. 
2004).  
 The ubiquitin system is often the target of cancer-related 
deregulation and is involved in processes such as oncogenic transformation 
and tumor progression.  Indeed, increased stability of positive regulators of 
proliferation (e.g. cyclins) can be achieved by lowering the activity or the 
levels of the specific enzymes necessary for their degradation.  Thus, the 
ubiquitinating enzymes specific for proto-oncoproteins can act as tumor 
suppressors. Accordingly, other ubiquitinating enzymes could be oncogenic 
if their specific function is to target tumor suppressors (e.g., p53, pRb, 
p27).  There are many established examples of both inactivation and 
overactivation of the ubiquitin pathway (especially of ubiquitin ligases) in 
human tumors(Nakayama and Nakayama 2006). 
  
 
Fig.4 (kindly provided by Dr Pagano) the picture describes a simplified model emphasizing 
the contribution of ubiquitin ligases to the regulation of CDKs.  There are, of course, crucial contributions 
from transcription, translation, translocation mechanisms, etc., which were omitted here to focus on how 
SCF and APC/C complexes work in concert to control and modulate CDK activity.  In brief, SCFSkp2 is an 
activator of both Cdk1 and Cdk2; SCFFbw7 is an inhibitor of Cdk2; and SCFß-Trcp contributes to turning 
Cdk1 off during S and G2 phase, and turning it on at G2/M.  With the exception of early M, APC/C is an 
inhibitor of CDKs. Notably, SCF ligases and APC/C reciprocally control each other:  in G1, APC/CCdh1 
induces the degradation of Skp2, thereby maintaining the G1 state, and in early mitosis SCFß-Trcp activates 
APC/CCdc20 by inducing the degradation of Emi1.  Thus, a picture emerges highlighting waves of different 
ubiquitin ligases that instantaneously modify components of the CDK regulatory network to maintain, 
activate or attenuate these drivers of the cell cycle.  At the same time, these ubiquitin ligases are 
themselves subjected to direct or indirect control by CDKs.   
 
 
 
 
 
 
 
Cyclin B proteolysis and mitosis exit 
 
 
At the heart of cell cycle relies the APC/C that controls mitosis exit through 
the degradation of cyclin B and Securin. The degradation of Securin signs 
the beginning of anaphase. Securin inhibits the activity of the protease 
Separase, that cleaves the cohesin glue holding the sister chromatid 
together. When the APC/C is activated Securin disappears thus allowing 
the activation of Separase and sister chromatid separation. Also Cyc B is 
degraded upon metaphase –anaphase transition, thus allowing mitosis exit 
through the inactivation of the M–Cyclin wave. Cyclin B degradation is 
essential for sister chromatid separation, the reduction in Cdk activity is 
required to relieve the inhibitory phosphorylation by the latter on the 
Separase (Stemmann, Zou et al. 2001). During metaphase a complex 
signalling network called spindle checkpoint ensure that only when all 
chromosome are correctly aligned on the metaphase plate the APC/C is 
activated, and chromosomes are segregated to the daughter cells 
(Musacchio and Hardwick 2002). Fig.5 shows the different phases of 
mitosis highlighting the role of cdk1.  
As cell proceed trough mitosis the APC/C is activated in two ways: its 
subunits are phosphorylated and its interaction with the activating protein  
Cdc20 increase. The phosphorylation of APC by cdk1 stimulates the 
activity of the latter towards the degradation of cyclin B while the 
interaction with Cdc20 is stimulated by a decrease in Cdk activity(Rudner, 
Hardwick et al. 2000; D'Angiolella, Mari et al. 2003). Thus the reduction in 
cdk activity is required to permit the activation of Separase and strengthen 
the interaction between Cdc20 and APC/C.  
In human cells as cell leave mitosis, the APC/C remains active but switches 
from depending on Cdc20 to depending on a related protein (Hct1/Cdh1/ 
Fizzy related) for its activity. Cdh1 is inhibithed by Cdk1(Jaspersen et 
al.,1999; Zacharie et al.,1998), and it is unclear whether the APC/C must 
remain phosphoryated in order to remain active, and if so, which kinases 
modifies it. Finally, in late G1, the reactivation of Cdks leads to the 
phosphorylation and inactivation of Hct1, terminating the activity of the 
APC/C until cells reach mitosis. 
Xenopus laevis relies only on the activity of Cdc20 during mitosis exit.  
Cdh1 is not expressed during the initial embryonic division. Furthermore, 
Cyclin B degradation during the early embryonic division is controlled by 
the activity of Protein Kinase A. PKA activity rises slightly after MPF 
inactivation and cyclin B degradation. By adding the regulatory subunits of 
PKA to cycling Xenopus laevis egg extract the degradation of cyclin B is 
prevented, while it can be reactivated with an excess of cAmp (Grieco, 
Porcellini et al. 1996). Many evidences suggested that PKA control Cdc25c 
and Wee1 by phosphorylation on Ser287(Ser216 in human) and Ser 549 
respectively(see above for further details) (Grieco, Avvedimento et al. 
1994; Grieco, Porcellini et al. 1996; Duckworth, Weaver et al. 2002; 
Stanford and Ruderman 2005). In lower eukaryotes like yeast the easiness 
of genetic manipulation has allowed a detailed dissection of the proteins 
implicated in mitosis exit. In fission yeast cdc25p (the homologue of the 
human Cdc25c) is inactivated during mitosis exit and this inactivation is 
required to control late mitotic events (Wolfe and Gould 2004).  The 
observed phenomenon during mitosis exit may be a widely conserved 
mechanism that regulates the timing of Cyc B degradation and late mitotic 
events in higher eucariotes. It is interesting to note that in xenopus laevis 
egg extract the inhibitory phosphorylation on Ser549 of Wee1 increases 
during mid mitosis after Cdc2 inactivation, furthermore the addition of a 
non degradable form of Cyc B strongly stimulates Wee1 inhibitory 
phosphorylation on Ser549(Stanford and Ruderman 2005) . In the current 
work we have investigated the role of Cdk1 inactivation (through tyr-15 
phosphorylation) during mitosis exit and its effect on cyc B degradation. 
We hypothesize that  PKA can contribute to MPF inactivation during 
mitosis exit through Wee1 or Cdc25c phosphorylation, thus allowing cyclin 
B degradation.  
 
 
 
 
 
 
Fig.5 Mitosis is divided operationally into six phases. At prophase, chromosome condensation initiates, 
the duplicated centrosomes separate, and some mitotic checkpoint proteins are recruited to kinetochores. 
With nuclear envelope disassembly at entry to prometaphase , the chromosome spill into the cytoplasm, 
and the mitotic checkpoint is activated at every unattached kinetochore. Microtubule capture at both 
kinetochores of a duplicated chromatid pair result in checkpoint silencing and chromosome alignment to a 
midzone using a combination of microtubule-motor activities and microtubuledunamics. After capture 
and congression of the final sister chromatid pair (metaphase) and the turnover of the previously produced 
inhibitor that send a wait anaphase signal, anaphase is initiated. During anaphase A the duplicated 
chromosome pairs are pulled apart. Then, during the subsequent anaphase B; the spindle elongates ; 
further separating the sister chromatids; and invaginations of the plasma membrane aroud the spindle 
midzone become apparent. At the end of telophase, the chromatin decondenses and the nuclear envelope 
reforms, while cytokinesis is competed.  
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        RESULTS 
 
 
 
 
CDK1- tyr15 phosphorylation during mitosis exit 
 
 
 
 
As discussed above M-phase exit relies on ubiquitin-dependent cyclin 
degradation initiated by activation of the ubiquitin ligase APC/C associated 
with its co-activator Cdc20 (APC/CCdc20)(King, Deshaies et al. 1996). 
Several APC/C subunits and Cdc20 undergo MPF dependent 
phosphorylation during M-phase(Peters 2002). Phosphorylation of APC/C 
stimulates its ubiquitin-ligase activity, however, phosphorylation of Cdc20 
hampers binding to APC/C (Yudkovsky, Shteinberg et al. 2000; Peters 
2002). Thus, MPF activity may play both positive and negative actions on 
APC/CCdc20 activation(Ciliberto, Lukacs et al. 2005). Evidence from 
Xenopus, yeast and human cell cycle systems, suggests that interruption of 
the MPF activation loop may also play a role for timing M-phase exit(Jin, 
Hardy et al. 1998; D'Angiolella, Costanzo et al. 2001; Tunquist and Maller 
2003; Wolfe and Gould 2004). To date, however, no direct evidence that 
the MPF activation loop is interrupted at M-phase exit has been provided. 
We set out to gain insight into this matter using the in vitro cell cycle 
system derived from Xenopus eggs(Murray and Kirschner 1989). Cell 
cycle progression is marked by fluctuations in MPF activity and cyclin B 
concentration during incubation at 23° C of activated egg extracts. The 
cdk1 phopsho-tyr-15 content varied during cell cycle(Solomon, Glotzer et 
al. 1990) (Fig. 1a). In samples take at 10 min intervals, the cdk1-phopsho-
tyr-15 signal decreased while MPF activity and cyclin content rose, reached 
a minimum when cyclins were degraded and MPF inactivated and 
reappeared as cyclins begun re-accumulating (Fig. 1a). Cdk1-tyr-15 
phopshorylation, hence, appeared to be progressively lost from the onset 
until the exit of M-phase. However, the analysis of samples taken at 2 min 
intervals revealed a strikingly different picture showing that cdk1 
underwent tyr-15 phosphorylation twice during this period (Fig. 1b, c). 
After initial decrease, that accompanied MPF activation and reached a 
minimum at the MPF activity peak (Fig. 1 b, c; 26-28 min), the cdk1-
phopsho-tyr-15 signal abruptly and transiently reappeared just prior to 
substantial cyclin degradation (Fig. 1b, c; 30, 32 min). Thereafter, when 
cyclin degradation was achieved, the signal rapidly decreased (Fig. 1b, c; 
34, 36 min). The changes in cdk1-tyr-15 phosphorylation were also 
confirmed by detection of cdk1 in anti cdk1-tyr-15 immunoprecipitates 
(Fig. 1d). We, next, determined the amount of cyclin and of cyclin-
associated cdk1, cdk1-phospho-tyr-15 and kinase activity in cyclin B1 and 
cyclin A immunoprecipitates from extracts aliquots taken across the 
mitosis-interphase transition. The cyclin B1-associated kinase activity 
decreased ahead of the cyclin B1 content (Fig. 1e, f). The decline in 
activity was accompanied by an increase in cyclin B1-associated cdk1-
phospho-tyr-15 signal (Fig. 1h). Cyclin A-associated kinase activity and 
cyclin A content decreased with parallel kinetics and begun by the time 
cyclin B1-associated kinase activity started to decline (Fig. 1e, g). The 
cdk1-phospho-tyr15 content in cyclin A immunoprecipitates was 
undetectable (Fig. 1h). 
 
 
 
 
 
 
 
 
  
Figure 1 Cdk1-tyr-
15 phosphorylation 
in cycling extracts. 
A cycling extract 
was incubated at 23 
°C in the presence of 
[S35]methionine. a, 
cyclin B abundance 
(detected by an 
autoradiograph of 
[S35]labelled 
extracts proteins; 
the position of 
cyclin B is 
indicated), cdk1-
phospho-tyr15 
(Cdk1-Y15-P) and 
cdk1 (Cdk1) 
contents (detected 
by immunoblot) 
from samples taken 
at 10 min intervals 
during incubation. 
b, cyclin B 
abundance (the 
position of cyclin B 
is indicated), cdk1-
phospho-tyr15 
(Cdk1-Y15-P), cdk1 
(Cdk1), cdc25c-
phospho-ser-287 
(Cdc25C-S287-P) 
and cdc25c 
(Cdc25C) contents 
(detected by 
immunoblot) from 
samples of a cycling 
extract taken at 2 
min intervals during 
incubation at 23 oC, 
across the mitosis-
interphase 
transition. c, histone 
H1 kinase activity in 
total extract from 
the samples 
described in b. d, 
cdk1 content in anti 
cdk1-phospho-tyr-
15 immunoprecipitates from samples taken at the indicated time points from the extract described in b. e, 
cyclin B1 (Cyc B1), cyclin B1-associated kinase activity (an autoradiograph of phosphorylated histone 
H1; Cyc B1-activity), cyclin A (Cyc A) and cyclin A-associated kinase activity (an autoradiograph of 
phosphorylated histone H1; Cyc A-activity) in cyclin B1 and cyclin A immunoprecipitations from 
samples of the same extract described in b. f, quantization, expressed as percent of peak value, of cyclin 
B1 content (open squares), cyclin B1-associated kinase activity (filled squares), and, g, of cyclin A 
content (open triangles) and cyclin A-associated kinase activity (filled triangles), from 
immunoprecipitations described in e. h, cdk1-phospho-tyr-15 and cdk1 contents in the 
immunoprecipitates described in e (Cyc B1 Ip and Cyc A Ip). 
 
  
            Cdk1-tyr-15 phosphorylation in CSF-arrested extracts. 
 
 
 
We determined whether similar changes in MPF activity, cdk1 
phosphorylation and cyclin content were also found at meiotic metaphase II 
exit. Extracts derived from non-activated eggs preserve the calcium-
sensitive Cytostatic Factor (CSF) activity that maintains metaphase II 
arrest(Tunquist and Maller 2003). In these extracts CSF is inactivated upon 
CaCl2 addition. Fig. 2a shows that, also during exit from metaphase II, 
cdk1 underwent a wave of tyr-15 phosphorylation that was maximal shortly 
after CaCl2 addition and decreased as cyclin degradation proceeded. 
Determination of the amount of cyclin B1 and of cyclin B1-associated 
cdk1, cdk1-phospho-tyr-15 and kinase activity in cyclin B1 
immunoprecipitates showed that MPF activity loss coincided with 
increased cdk1-tyr-15 phosphorylation rather than cyclin degradation (Fig. 
2b, c). These data suggest that the MPF activation loop must be interrupted 
at M-phase exit. Cdc25C inactivation correlates with its dephosphorylation 
at several, MPF-dependent, phosphorylayion sites and phosphorylation at 
the inhibitory site ser-287 (Hoffmann, Clarke et al. 1993; Hutchins, 
Dikovskaya et al. 2003). We analysed aliquots of cycling and CSF-arrested 
extracts for the presence of cdc25C-ser-287 phosphorylation. Cdc25C-ser-
287 and cdk1-tyr-15 phosphorylations inversely correlated with MPF 
activity and ensued when MPF activity begun declining (Figs, 1b, c; 2a, c). 
Cdc25C ser-287 phosphorylation continued to accumulate as cell cycle 
progressed towards interphase, while the cdk1 phospho-tyr-15 signal was 
lost along with the cyclin signal (Figs. 1b; 2a). Cdc25C also underwent a 
shift in migration on SDS/PAGE indicative of loss of multiple activating 
phosphorylations. Thus, interruption of the MPF-cdc25C activation loop 
marks M-phase exit. 
 
 
Figure 2 Cdk1-tyr-15 
phosphorylation in CSF-arrested 
extracts. A CSF-arrested extract was 
pre incubated with[S35]methionine to 
label extracts proteins. a, cyclin B 
abundance (the position of cyclin B 
is indicated), cdk1 phospho-
tyr15(Cdk1-Y15 P), cdk1 (Cdk1) , 
cdc25c-phospho-ser-287 (Cdc25C-
S287-P) and cdc25c (Cdc25C) 
contents (detected by immunoblot) 
from samples of a CSF-arrested 
extract taken at the indicated time 
points during incubation at 23 oC 
after CaCl2 addition. b, cyclin B1 
(Cyc B1), cyclin B1-associated 
kinase activity (Cyc B1-activity) and 
cdk1-phosphotyr15 (Cdk1-Y15-P) 
and cdk1 (Cdk1) contents in cyclin 
B1 immunoprecipitations from 
samples of a CSF-arrested extract 
taken at the indicated time points 
after CaCl2 
addition. c, quantisation, expressed 
as percent of peak value, of cyclin B1 
content(open squares), cyclin B1-
associated kinase activity (filled 
squares) from immunoprecipitations described in b. 
 
 
 
Preventing MPF activation loop interruption inhibits Cdc20-
APC/C interaction in cycling extracts 
 
 
 
Relevant for direct cdc25C-ser-287 phosphorylation, during unperturbed 
extract’s cell cycle, appears the regulated activities of CaMKII and PKA, 
CaMKII for the first mitotic interphase following CSF inactivation, while 
PKA for subsequent mitotic cycles(Grieco, Avvedimento et al. 1994; 
Grieco, Porcellini et al. 1996; Duckworth, Weaver et al. 2002; Hutchins, 
Dikovskaya et al. 2003). It has been shown that PKA also stimulates a 
phosphatase activity, in egg extracts, that removes multiple activating 
cdc25C phosphorylations(Grieco, Avvedimento et al. 1994). In addition, 
blocking PKA fluctuations prevents the mitosis-interphase transition while 
blocking CaMKII activation prevents the metaphase II-first interphase 
transition upon egg activation(Lorca, Cruzalegui et al. 1993; Grieco, 
Porcellini et al. 1996). We set out to determine the role for these kinases in 
the interruption of the MPF activation loop at M-phase exit. In cycling 
extract, PKA inhibition (by addition of excess recombinant, glutathione-S-
tranferase (GST)-fused, PKA regulatory subunit RIIb; GST-RII;) prevented 
cdc25C-ser-287 and cdk1-tyr-15 phosphorylations while cdc25c remained 
in its mitotic hyperphosphorylated state and cyclin stable (Fig. 3a, b). 
Reactivation of PKA was shortly followed by loss of multiple cdc25C 
activating phosphorylations, as indicated by appearance of faster migrating 
cdc25C forms, reappearance of cdc25C-ser-287, cdk1-tyr-15 
phosphorylations and cyclin degradation (Fig. 3a; - + cAMP; and 
supplementary Fig. S1). Thus, PKA inhibition prevented interruption of the 
MPF activation loop and blocked mitosis exit. To determine whether the 
block to mitosis exit was due to sustained MPF activity, we lowered cdk1 
activity by adding the cdk inhibitor roscovitine in PKA-inhibited extracts. 
Cdk inhibition rapidly restored cyclin degradation (Fig. 3b). Thus, 
interruption of the MPF activation loop appears the crucial function for 
PKA in mitosis exit. It is worth to note that also the kinase that 
phosphorylates cdk1-tyr-15, wee1, has been recently shown to undergo 
activating, PKA-inducible, phosphorylation just around the time of cyclin 
degradation(Stanford and Ruderman 2005). We asked why interruption of 
the MPF activation loop would be required for cyclin degradation. In this 
system, degradation tightly relies on binding of APC/C to its coactivator 
Cdc20 (Lorca, Castro et al. 1998; Peters 2002). We immunoprecipitated 
Cdc27, an APC/C subunit, and determined the amount of bound Cdc20 
from control extract samples, taken around the time of MPF inactivation, 
and from PKA-inhibited extract samples, taken at the same time points. In 
the control extract, very little Cdc20 co-precipitated with Cdc27 when MPF 
was at peak activity (Fig. 3 c). Binding increased during the time of MPF 
inactivation and was lost thereafter (Fig. 3 c). In the PKA-inhibited extract, 
APC/Ccdc20 binding was always poorly detectable (Fig. 3 b). APC/C-
cdc20 interaction was, however, restored in the PKA-inhibited extract after 
roscovitine addition (Fig. 3 c). These data indicate that interruption of the 
MPF activation loop is required for binding of APC/C to Cdc20. It is worth 
to note that it has been recently published that cycling extracts forced to use 
a mutant cdk1AF, refractory to inhibitory phosphorylation, enter mitosis, 
albeit with different kinetics than control extracts, but fail to activate the 
cyclin degradation pathway(Pomerening, Kim et al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Preventing MPF activation loop interruption inhibits Cdc20-APC/C interaction in cycling 
extracts. a, portions of a cycling extract were treated with GST, as control (Control), and with GST-RIIb 
(+ GST-RIIb) to inhibit PKA. Samples were taken at the indicated time points during incubation at 23° C. 
To portion of the GST-RIIb, cAMP (4 mM) was added at 40 min of incubation, to reactivate PKA, and 
samples taken at 45 min (- + cAMP; 4 mM, 1/30 extract volume). The Cdc25c phospho-ser-287 
(Cdc25C-S287-P), cdc25c (Cdc25C) and cdk1-phospho-tyr15 (Cdk1-Y15-P), contents were determined 
by immunoblot. b, cyclin B stability (the position of cyclin B is indicated) during incubation at 23° C in 
samples, taken at the indicated time points, from a control extract and portions of the same extract that 
weretreated with GST-RIIb and to which either roscovitine (2 mM; 1/30 extract volume), to inhibit cdk 
activity, or DMSO (1/30 extract volume), as control, were added. c, total Cdc27, cdc20 bound to Cdc27 
(IpCdc27/IbCdc20) and total histone H1 kinase activity (detected by phsophorylated histone H1 
autoradiograph; P-HH1) from samples of control, PKA-inhibited (+ GST-RIIb) and PKA-inhibited (+ 
GST-RIIb) plus roscovitine (added at 32 min; Rosco) extract portions, taken at the indicated time points 
during  incubation at 23° C. 
 
 
  
 
 
           MPF activity inhibits APC/CCdc20 activation through cdc20 
phopshorylation.  
 
 
 
Interruption of the MPF activation loop is required also for metaphase II 
exit. In CSF-arrested extracts, cdc25C ser-287 and cdk1-tyr-15 
phosphorylations were induced very rapidly after calcium addition (Fig. 
4a). Cdc25C-ser-287 and cdk1-tyr-15 phosphorylations, as well as cyclin 
degradation, were prevented by treatment with the CaMKII inhibitor 
peptide CaMKII Ntide (Fig. 4a, b). However, lowering cdk1 activity with 
roscovitine was unable to restore cyclin degradation in CaMKII-inhibited 
extracts (Fig. 3b). Thus, in the absence of other CaMKII-dependent events, 
loss of MPF activity is insufficient to activate cyclin degradation in CSF-
arrested extracts, in agreement with recently published observations(Liu 
and Maller 2005; Rauh, Schmidt et al. 2005). Nevertheless, if interruption 
of the MPF activation loop was required, although not sufficient, for cyclin 
degradation, supplying CSF-arrested extracts with a mutant cyclin B-cdk1 
complex, resistant to inhibitory phosphorylation (cdk1AF; thr 14 > ala, and 
tyr 15 > phe), should affect cyclin degradation upon calcium addition. We 
tested this hypothesis by treating CSF-arrested extract portions with 
recombinant human cyclin B1-cdk1 (cyclin B1-cdk1wt) or cyclin B1-
cdk1AF. Fig 4c shows that cyclin degradation was significantly delayed in 
the cyclin B1-cdk1AF-treated compared with the cyclin B1-cdk1-treated 
extract. Cyclin B1-cdk1wt treatment did not significantly affect cyclin 
degradation relatively to untreated extracts (possibly it induced a slight 
acceleration; supplementary Fig. S2). Cyclin degradation was, however, 
restored in the cyclin B1-cdk1AF-treated extract by lowering cdk activity 
with roscovitine (Fig. 4c). CSF-arrested extracts already contained some 
APC/C-Cdc20 complex, however, APC/C-Cdc20 interaction was 
significantly stimulated shortly after calcium addition (supplementary Fig. 
S3). Treatment with cyclin B1-cdk1AF, but not with cyclin B1-cdk1wt, 
significantly inhibited induction of APC/C-cdc20 interaction after calcium 
addition (Fig. 4d). In addition, in the absence of calcium, the sole addition 
of roscovitine was able to strongly stimulate APC/C-Cdc20 binding (Fig 
4e). 
APC/C and Cdc20 undergo phosphorylation in M-phase. By in vitro 
studies, Hershko and co-workers have shown that cdk-dependent 
phosphorylation of Cdc20 inhibits binding to APC/C, thus blocking 
APC/CCdc20 activation(Yudkovsky, Shteinberg et al. 2000). We asked 
whether Cdc20 phosphorylation affected binding to APC/C in egg extracts. 
CSF extracts were incubated with in vitro translated wild type human 
Cdc20 and a mutant Cdc20 version, non-phosphorylatable at 7 cdk1 
consensus sites, for 40 min, to induce Cdc20 phosphorylation (that caused 
retarded mobility on SDS/PAGE; Fig. 4f). After incubation, more 
phosphorylation-resistant mutant Cdc20 than wild type Cdc20 could be 
recovered in Cdc27 immunoprecipitates (Fig. 4 f), indicating that Cdc20 
phosphorylation hampered APC/C-Cdc20 interaction. 
 
 
 
 
 
 
 
 
 
 
  
                                                                                                                     Figure 4 MPF activity inhibits 
APC/CCdc20 activation through cdc20 
phopshorylation. a, CSF-arrested extract 
portions were pre-incubated with buffer, as 
control, or with the CaMKII inhbitor 
peptide CaMKII Ntide (0.5 mM) for 20 
min at 23° C. Then, extract samples were 
taken at the indicated time points of further 
incubation after CaCl2 addition. Cdc25c 
(Cdc25C), cdc25c-phospho-ser-287 
(Cdc25C-S287-P; short and long 
exposures of the immunoblot are shown; 
the asterisks mark non-specific signals) 
and cdk1-phospho-tyr15 (Cdk1-Y15-P), 
were visualised by immunoblotting. b , a 
CSF-arrested extract was pre-incubated 
with [S35]methionine for 30 min at 30° C 
to label extracts proteins. Then, 
cycloheximide was added to block protein 
synthesis, and extract portions were treated 
with buffer, as control, or with the 
CaMKII inhbitor peptide CaMKII Ntide 
and further incubated for 20 min at 23° C. 
Cyclin B stability is shown by an 
autoradiograph of [ S35]labeled 
extracts proteins (the position of 
cyclin B is indicated) in total 
extracts samples, taken at the 
indicated time points after CaCl2 
addition. To portions of the 
CaMKII Ntide treated extract 
either roscovitine (2 mM; 1/30 
extract volume), or DMSO (1/30 
extract volume) as control, were 
added 1 min after CaCl2. c, a CSF-
arrested extract was preincubated 
with [S]methionine for 30 min at 
30° C to label extracts proteins. 
Then, Cloheximide was added to 
block protein synthesis, and extract 
portions were treated wth buffer, as 
control, recombinant cyclin B1-
cdk1wt and cyclin B1-AF 
complexes nd incubation 
prolonged for further 20 min. 
Cyclin B stability is shown by an 
utoradiograph of [S35] labelled extracts proteins (the position of cyclin B is indicated)in total extracts 
samples, taken at the indicated time points after CaCl2 addition. To portions of the cyclin B1-AF -treated 
extract, either roscovitine (2 mM; 1/30 extract volume), or DMSO (1/30 extract volume) as control, were 
added 1 min after CaCl2. d,total Cdc27 and Cdc20 bound to Cdc27 (IpCdc27/IbCdc20) from CSF-
arrested samples, pre-incubated for 20 min at 23° C with recombinant cyclin B1-cdk1wt and cyclin B1-
AF complexes, taken at the indicated time points after CaCl2 addition (the time 0 sample received no 
CaCl2). e, Cdc27 (IpCdc27/IbCdc27) and cdc20 bound to Cdc27 (IpCdc27/IbCdc20) in Cdc27 
immunoprecipitates from CSF-arrested samples taken 5 min after the following additions, lane 1, DMSO, 
lane 2, 80 mM roscovitine, lane 3, 40 mM roscovitine, lane 4, 20 mM roscovitine ( each addition = 1/30 
extract volume). f, [S35]labelled Cdc20 wild type (wt) and a 7 phosphorylation sites mutant version (7A) 
were produced in reticulocyte lysates (lanes 1, 2). Labeled proteins were incubated with portions of a 
CSF-arrested extract containing cycloheximide for 30 min at 23 °C (lanes 3, 4). Cdc27 was, then, 
immunoprecipitated (Cdc 27 Ip) and the amount of bound wt (lane 7) and 7A (lane 8) Cdc20 detected by 
autoradiography. Lanes 5, 6, mock immunoprecipitations (Mk Ip). 
  
 
 
 
Wee1 and cdk1 physically associate in M-phase. 
  
 
By our analysis it cannot be excluded that the pathways leading to MPF 
inactivation via inhibitory phosphorylation take the upper hand only after 
initial degradation of small cyclin B amounts. In addition, the fact that 
cyclin degradation is activated when cdk1 activity is sustained by non-
degradable cyclin B suggests that a reduction in MPF activity is not 
absolutely required to initiate cyclin degradation. To gain further insight, 
we assayed cdk1 activity, in cdk1 immunoprecipitates from samples taken 
at 5 min intervals from the time of recombinant non-degradable sea urchin 
cyclin B (DB; at 100 nM) addition to interphase extracts. After the already 
described lag of 10-20 min (Solomon, Glotzer et al. 1990), we found that 
cdk1 activity did not increase continuously during incubation (Fig. 5a). 
Shortly after reaching M-phase activity levels (Fig. 5a; around 35-40 min 
after DB addition), activity underwent fluctuations with decrements up to 
20-25% relatively to M-phase activity (Fig. 5a; 40 to 60 min). Later, it 
further increased with relatively steady increments (Fig. 5a; from 60 min 
on). As previously demonstrated (Solomon, Glotzer et al. 1990), cdk1-tyr-
15 phosphorylation was markedly stimulated shortly after DB addition and 
decreased as cdk1 activity reached M-phase activity levels (Fig. 5b, 10 to 
40 min). However, the subsequent decrease in cdk1 activity was 
accompanied by a relative increase in cdk1-tyr-15 phosphorylation (albeit 
lower than that observed at early time points; Fig. 5b, 45-50-55 min). 
Cdc25C has been reported to be hyperphosphorylated at activating sites 
and non-phosphorylated at ser287 (Stanford and Ruderman 2005) under 
DB-induced M-phase arrest, making unlikely its involvement in the control 
of cdk1 phosphorylation under these conditions. Wee1 activity is believed 
to be down-regulated in M-phase by cdk1-dependent phosphorylations . 
Recent evidence indicated that wee1 undergoes phosphorylation at ser-549 
in M-phase of unperturbed cell cycle as well as under DB conditions 
(Stanford and Ruderman 2005). However, by in vitro kinase assays, the 
authors showed that wee1 ser-549 phosphorylation did not increase wee1 
activity and that wee1 isolated from interphase was slightly more active 
than that isolated from M-phase. What mechanism could, then, lead to 
mitotic cdk1-tyr-15 phosphorylation under DB conditions? We investigated 
whether wee1 and MPF could physically interact in M phase, as recently 
shown for the budding yeast wee1 homolog swe1 (Harvey, Charlet et al. 
2005), providing a possible mechanism for mitotic cdk1-tyr-15 
phosphorylation. Indeed, cdk1 could be detected in wee1 
immunoprecipitates from CSF-arrested extracts, while very little cdk1 co-
precipitated with wee1 from interphase samples (Fig 5c). Analysis of wee1-
cdk1 interaction under DB conditions revealed that it was easily detectable 
during the first 10-20 min after DB addition to an interphase extract, when 
cdk1 activity was still low (Fig. 5c). During the subsequent cdk1 activation 
period the complex significantly dissociated (Fig. 5c; 20-35 min). After 
cdk1 regained M-phase activity levels and then started to fluctuate, wee1-
cdk1 interaction was regained (Fig. 5c; 35-45 min). Analysis of phospho-
tyr-15 content in wee1-bound cdk1 showed that cdk1-phospho-tyr-15 
signal was detectable at early (interphase; Fig. 5d; 10 min) and, more 
pronouncedly, at later (M-phase; Fig. 5d; 40-45 min) time points after DB 
addition, further indicating that wee1-cdk1 interaction is accompanied by 
cdk1-tyr-15 phosphorylation. Upon prolonged incubation, when cdk1 
activity further increased, cdk1 appeared to dissociate from wee1 (Fig. 5d; 
90 min). Under our experimental conditions, degradation of full-length 
cyclin initiated 40-45 min from addition of nondegradable cyclin B (Fig. 
5e). To determine whether DB-cdk1 activity was affecting the timing of 
cyclin degradation, we inhibited cdk1 activity after significant cdk1 activity 
had been reached following DB addition and monitored full-length cyclin 
B degradation. Cdk1 inhibition slightly but consistently accelerated 
initiation of degradation (Figs. 5e, f). We asked whether wee1-cdk1 
interaction was detected during unperturbed M-phase exit in cycling 
extracts. Fig. 5g shows that across the mitosis-to-interphase transition, 
wee1 interacted with cdk1. Substantial interaction was detected at the peak 
of MPF activity and shortly after. Soon after cyclin B1 was degraded, 
wee1-cdk1 interaction was still maintained (Fig. 4d; 50 min) to be lost 
thereafter, possibly after significant wee1 dephosphorylation. Tyr-15-
phosphorylated cdk1 was also detected in wee1 immunoprecipitates, 
increasing as degradation of cyclin proceeded and disappearing thereafter 
(Fig. 4d; 45-50 min). Although we know that PKA inhibition delays cyclin 
degradation under DB conditions, further investigation will be required to 
establish the role for phosphorylations in the wee1-cdk1 interaction and in 
wee1 activity towards wee1-bound cdk1, the domains involved in binding 
as well as other potential other M-phase aspects for which interaction is 
relevant. Our data show that timely execution of M-phase exit in a 
vertebrate system relies on a proteolysis-independent control over MPF 
activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Wee1 and cdk1 physically associate in 
M-phase. a, histone H1 kinase activity in cdk1 Ips 
from samples of a CSF-arrested extract (M), an 
interphase extract (I; 40 min after CaCl2 and CHX 
additions) and from samples taken at the indicated 
time points after sea urchin DB (150nM) addition 
to an interphase extract. Left panel, shown is an 
autoradiograph of phosphorylated histone H1 (P-
HH1). Right panel, quantisation of cdk1 activity, 
expressed as percent of maximum, from three 
similar but independent experiments. b, Cdk1 
activity, cdk1-phospho-tyr15 and cdk1 content in 
cdk1 Ips from samples taken at the indicated time 
points after DB addition to an interphase extract. c, 
d, wee1 and cdk1 were immunoprecipitated from 
samples of CSF-arrested (M), interphase (I) 
extracts and samples taken at the indicated time 
points after DB addition to an interphase extract. 
Left panels, wee1 and wee1-associated cdk1 in 
wee1 Ips. Right panel, quantisation of histone H1 
kinase activity, expressed as percent of maximum, 
in cdk1 Ips. In d, was also detected the cdk1-
phospho-tyr15 content in wee1 Ips. e, f, Full-
length, [S35]labelled, xenopus cyclin B1 was added 
to two independent interphase extracts along with 
DB. The extracts were spilt into two portions and 
DMSO, as control, or roscovitine (10 mM) were 
added after 33 min incubation, samples were, then, 
taken at the indicated time points after DB 
addition. Shown are autoradiographs and 
quantisations, as percent, of remaining 
[S35]labelled, full-length, cyclin B1. g, Cyclin B1 
content (by immunoblot) and cyclin B1 associated 
activity from a cycling extract across the mitosis-to 
interphase transition. From the same samples, 
wee1 was immunoprecipitated (Wee1 Ip) and 
wee1, wee1-associated cdk1-phospho-tyr15 and 
cdk1 were visualised by immunobloting 
 
 
       Discussion 
 
In the current work  we show that, at M-phase exit, cyclin degradation 
requires loss of MPF activity by inhibitory cdk1 phosphorylation. 
Phosphorylation depends on activation of pathways, like those that relay on 
CaMKII and PKA activities, that antagonize the MPF activation loop. 
Nevertheless, M-phase exit strictly relies on proteolysis(King, Deshaies et 
al. 1996). Thus, the action of inhibitory pathways is insufficient to lower 
MPF activity to the levels required to exit M-phase if proteolysis cannot 
take over. We propose that proteolysis and inhibitory cdk1 phosphorylation 
are interconnected in a MPF inactivation loop for M-phase exit. Initial, 
phosphorylation-dependent, loss of MPF activity stimulates APC/CCdc20 
activation. MPF degradation further weakens the activation loop promoting 
inhibitory phosphorylation. Consequent additional MPF activity loss 
further helps APC/CCdc20 activation. We cannot exclude that degradation 
of a small pool of cyclin initiates the loop. However, full activation of the 
degradation pathway requires further reduction of MPF activity by 
inhibitory phosphorylation, otherwise M-phase exit is prevented.  
The inhibitory phosphorylation on cdk1 can take place by the interaction of 
cdk1 with wee1 during mitosis it is interesting to note that the same 
mechanism is functional in yeast where cdk1 form a complex with wee1 
thus blocking the autoamplification loop.  
 During initial embryonic division the dynamic of Xenopus laevis system 
ensure the rapid oscillation of MPF. At the onset of mitosis MPF 
phosphorylates cdc20 thus preventing cyc B degradation. Slowly, APC 
phosphorylated by cdk1 builds up until it overcomes phosphorylated 
Cdc20, APC/C Cdc20 is formed, cyclin B is degraded.  
Initial loss of cdk1 activity through degradation is rapidly amplified by 
MPF inactivation that further increases the pool of active and 
dephosphorylated cdc20. 
We have initial evidences that the same mechanism of cdk inactivation 
during mitosis exit operates also in human cells. We have followed cyclin 
B accumulation tyr 15 phosphorylation of cdk1 for 12 hours after release 
from a double thymidine block in hela cells. We found that tyr-15 is high 
during S-phase until cell reach mitosis where the tyr-15 signal completely 
disappear,  tyr-15 phosphorylated cdk1 increases sharply after cyclin B 
degradation to disappear thereafter(D’ angiolella and grieco submitted). We 
are investiganting the functional relevance of this phosphorylation in 
human cells.  
  In xenopus laevis egg extract the absence of checkpoints allow the rapid 
alternation of S-phase and M-phase. What happens during spindle 
checkpoint? How cdk activity is controlled during checkpoint activation?  
We have previously shown that cdk activity is required to sustain the 
spindle checkpoint, we speculate that a branch of the complex signaling 
network present during an active spindle checkpoint is deputed to the 
control of cdk activity. 
Cells undergo rapid adaptation upon spindle checkpoint if Cdc25c activity 
is weakened (Grieco and D’ Angiolella in preparation), thus it can be 
possible that a localized control of Cdk activity (on the mitotic spindle for 
example) is important for the timing of cyclin B degradation and the 
fidelity of sister chromatid disjunction. 
We speculate that the inactivation of cdk1 by tyr 15 phosphorylation can be 
a primeval mechanism to ensue mitosis exit. During evolution, degradation 
take over cdk activity control, to ensure the irreversibility of mitosis exit. 
Given the reduced wee1 function between meiosis I and II(only single 
cdk1-thr-14 inhibitory phosphorylation could be performed by myt1 at this 
developmental stage)(Minshull, Murray et al. 1991; Iwabuchi, Ohsumi et 
al. 2000; Nakajo, Yoshitome et al. 2000) our observations may also explain 
why the cyclin degradation pathway is only partially activated during this 
period, helping the transition to proceed without intervening S-phase and 
loss of sister chromatid cohesion. 
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